Please enable JavaScript to continue using this application.

Compare $COGT vs $SRRK | Chartloom

Compare

$COGT vs $SRRK

Cogent Biosciences Inc · Scholar Rock Holding Corp

COGT

Cogent Biosciences Inc

SRRK

Scholar Rock Holding Corp

Compare $COGT vs $SRRK

Comparing Cogent Biosciences Inc and Scholar Rock Holding Corp

COGTCogent Biosciences Inc

SRRKScholar Rock Holding Corp

COGTCogent Biosciences Inc

Market cap

$5.30B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

24.59x

Rev growth (TTM)

—

YTD performance

-10.8%

52W performance

99.0%

FCF yield

-5.8%

SRRKScholar Rock Holding Corp

Market cap

$5.06B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

122.55x

Rev growth (TTM)

—

YTD performance

-1.4%

52W performance

9.0%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COGT

SRRK

Detailed metrics comparison

COGT

Cogent Biosciences Inc

SRRK

Scholar Rock Holding Corp

Market Cap

COGT$5.30B

SRRK$5.06B

Enterprise Value

COGT$5.34B

SRRK$4.81B

Price

COGT$31.00

SRRK$42.19

P/E Ratio

COGTN/A

SRRKN/A

P/S Ratio

COGT232.42x

SRRK120.52x

EV/Sales

COGT234.24x

SRRK115.43x

EV/EBITDA

COGT0.00x

SRRK0.00x

P/B Ratio

COGT10.11x

SRRK22.46x

P/FCF Ratio

COGTN/A

SRRKN/A

EV/FCF

COGT-17.27x

SRRK-16.21x

PEG Ratio

COGTN/A

SRRKN/A

Forward P/E (NTM)

COGTN/A

SRRKN/A

Forward P/S (NTM)

COGT24.59x

SRRK122.55x

Revenue (TTM)

COGT$0

SRRK$0

Revenue Growth (YoY)

COGTN/A

SRRKN/A

Forward Rev Growth

COGT2636.5%

SRRK2628.0%

Gross Margin (TTM)

COGT0.0%

SRRK0.0%

Operating Margin (TTM)

COGT0.0%

SRRK0.0%

EBITDA Margin (TTM)

COGT0.0%

SRRK0.0%

Net Margin (TTM)

COGT0.0%

SRRK0.0%

FCF Margin (TTM)

COGTN/A

SRRKN/A

Net Income (TTM)

COGT$-332M

SRRK$-406M

FCF (TTM)

COGT$-309M

SRRK$-297M

EPS (TTM)

COGT-$1.94

SRRK-$3.11

ROE (TTM)

COGT-7257.0%

SRRK-15912.0%

ROA (TTM)

COGT-4865.0%

SRRK-8660.0%

ROIC (TTM)

COGT-5402.0%

SRRK-10069.0%

Cash

COGT$181M

SRRK$437M

Debt

COGT$223M

SRRK$196M

Net Cash/Debt

COGT$-42M

SRRK$241M

Current Ratio (TTM)

COGT13.57x

SRRK7.02x

Quick Ratio (TTM)

COGT13.36x

SRRK6.84x

Debt/Equity (TTM)

COGT0.42x

SRRK0.77x

Debt/Assets (TTM)

COGT0.0%

SRRK0.0%

Interest Coverage (TTM)

COGTN/A

SRRKN/A

Net Debt/EBITDA (TTM)

COGT0.00x

SRRK0.00x

Beta

COGT0.34

SRRK0.76

52W Performance

COGT99.0%

SRRK9.0%

YTD Performance

COGT-10.8%

SRRK-1.4%

% from 52W High

COGT-29.1%

SRRK-31.7%

% from 52W Low

COGT125.0%

SRRK55.9%

Asset Turnover (TTM)

COGT0.36x

SRRK0.16x

FCF Yield (TTM)

COGT-5.8%

SRRK-5.9%

Earnings Yield (TTM)

COGT-6.3%

SRRK-8.0%

Dividend Yield (TTM)

COGTN/A

SRRKN/A

Rule of 40

COGT0.0

SRRK0.0

EV/GP/RG

COGTN/A

SRRKN/A

Ticker research

View COGT research View SRRK research

Metric	COGT Cogent Biosciences Inc	SRRK Scholar Rock Holding Corp
Market & Valuation
Market Cap	$5.30B	$5.06B
Enterprise Value	$5.34B	$4.81B
Price	$31.00	$42.19
P/E Ratio	N/A	N/A
P/S Ratio	232.42x	120.52x
EV/Sales	234.24x	115.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	10.11x	22.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.27x	-16.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.59x	122.55x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	2636.5%	2628.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-332M	$-406M
FCF (TTM)	$-309M	$-297M
EPS (TTM)	-$1.94	-$3.11
ROE (TTM)	-7257.0%	-15912.0%
ROA (TTM)	-4865.0%	-8660.0%
ROIC (TTM)	-5402.0%	-10069.0%
Financial Health
Cash	$181M	$437M
Debt	$223M	$196M
Net Cash/Debt	$-42M	$241M
Current Ratio (TTM)	13.57x	7.02x
Quick Ratio (TTM)	13.36x	6.84x
Debt/Equity (TTM)	0.42x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	0.76
52W Performance	99.0%	9.0%
YTD Performance	-10.8%	-1.4%
% from 52W High	-29.1%	-31.7%
% from 52W Low	125.0%	55.9%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.16x
FCF Yield (TTM)	-5.8%	-5.9%
Earnings Yield (TTM)	-6.3%	-8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View COGT research	View SRRK research

Valuation

P/S Ratio

SRRK

120.52x

COGT

232.42x

EV/FCF

COGT

-17.27x

SRRK

-16.21x

Growth & revenue

Forward Revenue Growth

COGT

2636.5%

SRRK

2628.0%

Profitability & performance

Gross Margin

COGT

0.0%

SRRK

0.0%

ROE

COGT

-7257.0%

SRRK

-15912.0%

FCF Yield %

COGT

-5.8%

SRRK

-5.9%

52-Week Performance

COGT

99.0%

SRRK

9.0%

Detailed metrics comparison

COGT

Cogent Biosciences Inc

SRRK

Scholar Rock Holding Corp

Market Cap

COGT$5.30B

SRRK$5.06B

Enterprise Value

COGT$5.34B

SRRK$4.81B

Price

COGT$31.00

SRRK$42.19

P/E Ratio

COGTN/A

SRRKN/A

P/S Ratio

COGT232.42x

SRRK120.52x

EV/Sales

COGT234.24x

SRRK115.43x

EV/EBITDA

COGT0.00x

SRRK0.00x

P/B Ratio

COGT10.11x

SRRK22.46x

P/FCF Ratio

COGTN/A

SRRKN/A

EV/FCF

COGT-17.27x

SRRK-16.21x

PEG Ratio

COGTN/A

SRRKN/A

Forward P/E (NTM)

COGTN/A

SRRKN/A

Forward P/S (NTM)

COGT24.59x

SRRK122.55x

Revenue (TTM)

COGT$0

SRRK$0

Revenue Growth (YoY)

COGTN/A

SRRKN/A

Forward Rev Growth

COGT2636.5%

SRRK2628.0%

Gross Margin (TTM)

COGT0.0%

SRRK0.0%

Operating Margin (TTM)

COGT0.0%

SRRK0.0%

EBITDA Margin (TTM)

COGT0.0%

SRRK0.0%

Net Margin (TTM)

COGT0.0%

SRRK0.0%

FCF Margin (TTM)

COGTN/A

SRRKN/A

Net Income (TTM)

COGT$-332M

SRRK$-406M

FCF (TTM)

COGT$-309M

SRRK$-297M

EPS (TTM)

COGT-$1.94

SRRK-$3.11

ROE (TTM)

COGT-7257.0%

SRRK-15912.0%

ROA (TTM)

COGT-4865.0%

SRRK-8660.0%

ROIC (TTM)

COGT-5402.0%

SRRK-10069.0%

Cash

COGT$181M

SRRK$437M

Debt

COGT$223M

SRRK$196M

Net Cash/Debt

COGT$-42M

SRRK$241M

Current Ratio (TTM)

COGT13.57x

SRRK7.02x

Quick Ratio (TTM)

COGT13.36x

SRRK6.84x

Debt/Equity (TTM)

COGT0.42x

SRRK0.77x

Debt/Assets (TTM)

COGT0.0%

SRRK0.0%

Interest Coverage (TTM)

COGTN/A

SRRKN/A

Net Debt/EBITDA (TTM)

COGT0.00x

SRRK0.00x

Beta

COGT0.34

SRRK0.76

52W Performance

COGT99.0%

SRRK9.0%

YTD Performance

COGT-10.8%

SRRK-1.4%

% from 52W High

COGT-29.1%

SRRK-31.7%

% from 52W Low

COGT125.0%

SRRK55.9%

Asset Turnover (TTM)

COGT0.36x

SRRK0.16x

FCF Yield (TTM)

COGT-5.8%

SRRK-5.9%

Earnings Yield (TTM)

COGT-6.3%

SRRK-8.0%

Dividend Yield (TTM)

COGTN/A

SRRKN/A

Rule of 40

COGT0.0

SRRK0.0

EV/GP/RG

COGTN/A

SRRKN/A

Ticker research

View COGT research View SRRK research

Metric	COGT Cogent Biosciences Inc	SRRK Scholar Rock Holding Corp
Market & Valuation
Market Cap	$5.30B	$5.06B
Enterprise Value	$5.34B	$4.81B
Price	$31.00	$42.19
P/E Ratio	N/A	N/A
P/S Ratio	232.42x	120.52x
EV/Sales	234.24x	115.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	10.11x	22.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.27x	-16.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.59x	122.55x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	2636.5%	2628.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-332M	$-406M
FCF (TTM)	$-309M	$-297M
EPS (TTM)	-$1.94	-$3.11
ROE (TTM)	-7257.0%	-15912.0%
ROA (TTM)	-4865.0%	-8660.0%
ROIC (TTM)	-5402.0%	-10069.0%
Financial Health
Cash	$181M	$437M
Debt	$223M	$196M
Net Cash/Debt	$-42M	$241M
Current Ratio (TTM)	13.57x	7.02x
Quick Ratio (TTM)	13.36x	6.84x
Debt/Equity (TTM)	0.42x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	0.76
52W Performance	99.0%	9.0%
YTD Performance	-10.8%	-1.4%
% from 52W High	-29.1%	-31.7%
% from 52W Low	125.0%	55.9%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.16x
FCF Yield (TTM)	-5.8%	-5.9%
Earnings Yield (TTM)	-6.3%	-8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View COGT research	View SRRK research